Your institution may have access to this item. Find your institution then sign in to continue.
Title
People.
Abstract
The article announces executive changes in the biotechnology industry as of April 2010, including Thomas Hofstaetter as president and chief executive officer (CEO) and Alan Shaw as chairman of the board of VaxInnate, Mark Leuchtenberger as president and CEO of Rib-X Pharmaceuticals and Craig W. Carlson as chief financial officer (CFO) of Hana Biosciences.